Young children may perceive a chemical tablet, such as those used to die fabrics, as a piece of candy and may subsequently attempt to eat the tablet. While in some cases the tablet may be quite harmless if ingested, swallowing of the tablet is undesirable both to prevent the risk that ingestion of the tablet may harm the child and to prevent possible choking. This disclosure relates generally to substance holders, and more specifically, to holders that allow dispensing of a held substance into and out of the holder, such as through diffusion, while decreasing the likelihood of ingestion. Containers for dispensing chemicals or restricting flow through a holder are found in U.S. Pat. Nos. 3,165,910, 3,657,994, 4,350,666, 4,555,819, 4,860,929, 5,593,648, 5,623,865 and 6,024,012, the disclosures of which are incorporated herein by reference.
The present discloser is directed to a tablet holder. The tablet holder includes a retainer portion and an extension portion that is adapted to engage selectively with the retainer portion and extend therefrom in a plurality of directions. In some embodiments, the extension portion extends parallel to a plane formed by a diffusion surface in the retainer portion.
Although the disclosed holder may be used to encase any substance for controllably dispensing a compound when submerged in a liquid, the following discussion will focus on holder 10 in appropriate configurations for uses similar to that previously discussed, thereby preventing young children, who may perceive a chemical tablet as a piece of candy, from eating tablet 12. Therefore, users are protected by limiting access to the holder's contents while diffusion is allowed through the holder to maintain complete functionality of the substance contained within the holder during use.
As depicted in
At least one surface of holder 10 is considered a diffusion surface 32, as shown in
Extension portion 28 is configured to extend away from retainer portion 26 to restrict ingestion of the holder and the tablet it contains. This may be accomplished by extension portion 28 including one or more flanges 42 extending beyond outer periphery 38 of retainer portion 26 in a plurality of directions. In some embodiments flanges 42 extend in directions parallel to plane 36, formed by the diffusion surface of retainer portion 26.
During use, holder 10 and encased tablet 12 are placed in a container of liquid, such as water, as previously described. Tablet 12 is able to dissolve because the liquid enters and exits holder 10 through perforations 34 that provide access to tablet 12. The number and size of perforations 34 may be selected to allow relatively uninhibited movement of water into and out of chamber 30 so that tablet 12 may quickly dissolve and be dispensed. Alternatively, the number and size of perforations 34 may be designed to limit the rate at which the chemicals of tablet 12 are dispensed.
Perforations 34 may be of any shape or dimension as long as tablet 12 is fully contained within holder 10 prior to use. In the embodiments shown, the tablet remains in chamber 30 until the majority of diffusion is complete. Prior to use, perforations 34 may be blocked to prevent moisture from entering chamber 30. This may be achieved by barrier 44, shown in
Retainer portion 26 and extension portion 28 may be adapted to allow a user to selectively access chamber 30 by separating the retainer portion from the extension portion 28. Thus, retainer portion 26 may be separable from flanges 42 of extension portion 28, such that flanges 42 may also be used to open chamber 30 to allow an adult to insert a replacement tablet 12 by prying or twisting flanges 42. In some embodiments, such as that shown in
The shape and size of holder 10 may assist in preventing swallowing or other methods of ingesting the chemicals of tablet 12. For example, flanges 42 may protrude sufficiently far away from retainer portion 26 that holder 10 is incapable of entering or lodging in a child's throat. To accomplish this, some embodiments include at least two flanges extending in opposing directions. Although flanges 42, as shown in
Flanges 42 may also be used to facilitate motion of holder 10 within a container of liquid to increase mixing of the tablet chemicals with the surrounding liquid. Additionally, an out-of-plane flange 42, such as that shown in
As shown in
In some embodiments, holder 10 includes a fully integrated retainer portion 26 and extension portion 28, as shown in
In the example shown in
As shown in
In still other embodiments, an extension portion 28 may be connected to both ends of retainer portion 26, such as the spool-like configuration shown in
In the case of a dye tablet holder, retainer portion 26 and/or extension portion 28 may be colored to indicate the color of dye contained. Alternatively, at least a region of retainer portion 26 or extension portion 28, depending on the location of chamber 30, is translucent so that the color of tablet 12 and its diffusion progress are directly viewable.
It is believed that the disclosure set forth above encompasses multiple distinct inventions with independent utility. While each of these inventions has been disclosed in its preferred form, the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense as numerous variations are possible. The subject matter of the inventions includes all novel and non-obvious combinations and subcombinations of the various elements, features, functions and/or properties disclosed herein. Similarly, where any claim recites “a” or “a first” element or the equivalent thereof, such claim should be understood to include incorporation of one or more such elements, neither requiring nor excluding two or more such elements.
Inventions embodied in various combinations and subcombinations of features, functions, elements, and/or properties may be claimed through presentation of new claims in a related application. Such new claims, whether they are directed to a different invention or directed to the same invention, whether different, broader, narrower or equal in scope to the original claims, are also regarded as included within the subject matter of the inventions of the present disclosure.
This application claims priority under 35 U.S.C. 119(e) to U.S. Provisional Patent Application No. 60/485,673 entitled “Diffusion-Enabled, Ingestion Inhibitor,” filed Jul. 7, 2003, the disclosure of which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
60485673 | Jul 2003 | US |